NEW YORK (GenomeWeb News) – ILS announced on Friday it has acquired the Morrisville, N.C. site of Beckman Coulter Genomics and formed ILS Genomics.

ILS Genomics provides services in genotyping and gene expression, as well as biologics product safety testing. Sam Tetlow, chief business officer for ILS, was named general manager of ILS Genomics.

The company said that it has capabilities in key platforms for gene expression profiling, including Affymetrix, Illumina, Agilent, Sequenom, and Life Technologies business Applied Biosystems.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: co-evolutionary signatures of insect hosts and bacterial symbionts, distinct transcript isoforms of high-grade ovarian cancer, and more.

Adam Rutherford discusses genetic genealogy at the Guardian.

Portions of the US 21st Century Cures Act are raising some safety concerns.

David Dobbs writes at Buzzfeed that genomics has delivered little on its promises.